Meet 52 richest Indians in Pharma Healthcare domain

Published On 2022-09-21 14:03 GMT   |   Update On 2022-09-21 14:03 GMT

New Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun India Rich List 2022.IIFL Wealth in association with Hurun India launched the 11th annual ranking of the richest individuals in India- IIFL Wealth Hurun India Rich List 2022. As per the list, India's rich cumulatively constitute Rs 100 lakh crore...

Login or Register to read the full article

New Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun India Rich List 2022.

IIFL Wealth in association with Hurun India launched the 11th annual ranking of the richest individuals in India- IIFL Wealth Hurun India Rich List 2022. As per the list, India's rich cumulatively constitute Rs 100 lakh crore of wealth in 2022.

The founder of Serum Institute of India (SII), nicknamed 'Vaccine King of India', Cyrus S Poonawalla has topped the list among pharma entrepreneurs with 25 percent change in his total wealth to Rs 2,05,400 crore.

Poonawalla (81) has moved to the third rank in the IIFL Wealth Hurun India Rich List 2022 after his wealth increased by 25% or Rs 41,700 crore in the last year. His privately held company is the world's biggest vaccine maker and has recently developed the country's first cervical cancer shot that will hit the market soon. Apart from COVID shots, the SII's Indian plants make vaccines for diphtheria, BCG, measles, rubella and other conditions. He is also considering setting up its first manufacturing plant in Africa as he looks to expand globally.

Ranking second on the list among pharma and health sector is pharma tycoon Dilip Shanghvi with 12 percent change in wealth to Rs 1,33,500 crore. Shanghvi (66), who is the founder and head of India's largest drug maker Sun Pharmaceutical Industries, moved up two ranks to the ninth rank with his wealth increasing by 12% to Rs 1,33,500 crore. In the last five years, his wealth has moved up by 50% or Rs 43,800 crore as the pharma major expanded its global operations.

Meanwhile, 'Biotech Queen' Kiran Mazumdar Shaw has been overthrown by founder of Nykaa, Falguni Nayar and her rank slipped to 67th position with wealth of Rs 24,800 crore.

The pharma sector contributed the highest to the list with 126 entries and India is now an acknowledged supplier of generic drugs to the world. There are 8 new additions to the list while 12 lost the status to be featured in the list. The pharma industry has also greatly benefited from the pandemic-induced need for vaccines and increased focus on drugs. Four from the pharmaceutical sector lost their dollar billionaire status. There are 56 individuals in the list deriving their wealth from listed pharma companies, of which 79% saw their wealth declining cumulatively by Rs 93,400 crore.

IIFL Wealth Hurun India Rich List 2022 – Insights from the Pharma and Health Sector

Rank

Name

Wealth INR Cr

Company

Industry

1

Cyrus S Poonawalla & family

2,05,400

Serum Institute of India

Pharmaceuticals

2

Dilip Shanghvi

1,33,500

Sun Pharmaceutical Industries

Pharmaceuticals

3

Murali Divi & family

56,200

Divi's Laboratories

Pharmaceuticals

4

B Parthasaradhi Reddy & family

39,200

Hetero Labs

Pharmaceuticals

5

Pankaj Patel & family

34,900

Zydus Lifesciences

Pharmaceuticals

6

Samir Mehta & family

27,000

Torrent Pharmaceuticals

Pharmaceuticals

6

Sudhir Mehta & family

27,000

Torrent Pharmaceuticals

Pharmaceuticals

7

Kiran Mazumdar-Shaw

24,800

Biocon

Pharmaceuticals

8

Mahendra Prasad

24,700

Aristo Pharmaceuticals

Pharmaceuticals

9

Leena Gandhi Tewari

19,600

USV

Pharmaceuticals

10

Yusuf Hamied & family

18,500

Cipla

Pharmaceuticals

11

Manju D Gupta & family

16,100

Lupin

Pharmaceuticals

12

M Satyanarayana Reddy & family

16,000

MSN Laboratories

Pharmaceuticals

13

Binish Hasmukh Chudgar & family

15,300

Intas Pharmaceuticals

Pharmaceuticals

13

Nimish Hasmukh Chudgar & family

15,300

Intas Pharmaceuticals

Pharmaceuticals

13

Urmish Hasmukh Chudgar & family

15,300

Intas Pharmaceuticals

Pharmaceuticals

14

PV Ramprasad Reddy

14,400

Aurobindo Pharma

Pharmaceuticals

15

Satish Ramanlal Mehta & family

13,500

Emcure Pharmaceuticals

Pharmaceuticals

16

Girdharilal Bawri & family

12,800

Macleods Pharmaceuticals

Pharmaceuticals

17

Basudeo Narain Singh & family

12,600

Alkem Laboratories

Pharmaceuticals

18

Arvind Lal & family

12,500

Dr. Lal PathLabs

Healthcare

19

Banwarilal Bawri & family

12,500

Macleods Pharmaceuticals

Pharmaceuticals

19

Rajendra Agarwal

12,500

Macleods Pharmaceuticals

Pharmaceuticals

20

K Satish Reddy & family

11,300

Dr. Reddy's Laboratories

Pharmaceuticals

21

Gangadhar Motiram Warke & family

1,400

Hi Media Laboratories

Pharmaceuticals

21

LV Subba Reddy & family

1,400

Virchow Laboratories

Pharmaceuticals

21

M Venkat Pratap Reddy & family

1,400

MSN Laboratories

Pharmaceuticals

22

Manish Doshi & Family

1,300

Amoli Organics

Pharmaceuticals

22

Pallavi Bharat Mehta & family

1,300

J B Chemicals & Pharmaceuticals

Pharmaceuticals

22

Rajesh Kumar

1,300

Alkem Laboratories

Pharmaceuticals

22

Shirish Mody & family

1,300

J B Chemicals & Pharmaceuticals

Pharmaceuticals

22

Bharat Daftary & family

1,200

Bharat Serums & Vaccines

Pharmaceuticals

22

Gautam Daftary & family

1,200

Bharat Serums & Vaccines

Pharmaceuticals

22

Janmejay Rajnikant Vyas

1,200

Dishman Carbogen Amcis

Pharmaceuticals

22

Kishor Kumar Singh

1,200

Alkem Laboratories

Pharmaceuticals

22

Mohan Anand Chandavarkar & family

1,200

FDC

Pharmaceuticals

22

Nawal Kishore Singh

1,200

Alkem Laboratories

Pharmaceuticals

22

Prashant Malladi

1,200

Malladi Drugs & Pharmaceuticals

Pharmaceuticals

22

Rajeev Ranjan

1,200

Alkem Laboratories

Pharmaceuticals

23

Ashok Anand Chandavarkar & family

1,100

FDC

Pharmaceuticals

23

Mark Saldanha

1,100

Marksans Pharma

Pharmaceuticals

23

Meera Ramdas Chandavarkar & family

1,100

FDC

Pharmaceuticals

23

Sunil Sachdeva & family

1,100

Medanta Medicity

Healthcare

23

Yalavarthy Shyam Prasad & family

1,100

Laurus Labs

Pharmaceuticals

24

Alok Kumar

1,000

Alkem Laboratories

Pharmaceuticals

24

Arun Kumar Pillai

1,000

Sequent Scientific

Pharmaceuticals

24

Ashok Kumar

1,000

Alkem Laboratories

Pharmaceuticals

24

Deepak Kumar Singh

1,000

Alkem Laboratories

Pharmaceuticals

24

M Sivakumaran

1,000

Aurobindo Pharma

Pharmaceuticals

24

Nalla G Palaniswami & family

1,000

Kovai Medical Center & Hospital

Healthcare

24

Pranabh Mody & family

1,000

J B Chemicals & Pharmaceuticals

Pharmaceuticals

24

PVA Mohandas & family

1,000

MIOT Hospitals

Healthcare

Commenting on the launch, Yatin Shah, Co-Founder & Joint CEO, IIFL Wealth, said, "IIFL Wealth Hurun India Rich List 2022, is a comprehensive overview of a plethora of factors that have significantly contributed to the rising wealth of India and we are proud to associate with the same. Despite the slump in the economy owing to geo-political challenges, volatility in global financial markets, and sharp spike in oil prices, India has successfully made an impression on the world's economy/wealth map. Pharmaceuticals, chemical & petrochemicals, IT, and financial services amongst others are some of the key sectors substantially contributing to wealth creation. It is exhilarating to see the entrepreneurial ecosystem of India contribute a significant amount to this list with the rising number of women entrepreneurs and uptick in self-made entrepreneurs. There are 65 founders of 37 unicorns along with 14 professional managers who have emerged as the cornerstone of wealth creation this time in the list."

Commenting on the launch, Anas Rahman Junaid, MD and Chief Researcher, Hurun India, said, "Post-pandemic, some of the COVID winners such as generic pharma, diagnostics, and Software & Services faced headwinds. While pharma and diagnostics dropped mainly on account of subdued demand post COVID, Software & Services industry has taken a beating due to fears of a recession in the developed markets that house most of the outsourcing clients."

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News